(Q37606115)

21 August 2017

1 reference

title

PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches (English)

1 reference

21 August 2017

1 reference

2

Paul Cumming

1 reference

21 August 2017

Yoshitaka Kumakura

1

1 reference

PubMed ID

19793723

21 August 2017

language of work or name

1 reference

1 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

15

1 reference

21 August 2017

6

1 reference

21 August 2017

635-650

1 reference

Biological imaging and the molecular basis of dopaminergic diseases

21 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Working memory capacity predicts dopamine synthesis capacity in the human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Loss of metabolites from monkey striatum during PET with FDOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

An in vivo microdialysis study of striatal 6-[18F]fluoro-L-m-tyrosine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Personality traits and brain dopaminergic function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Dopamine in amygdala gates limbic processing of aversive stimuli in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Personality traits and striatal dopamine synthesis capacity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Clinical and [18F] dopa PET findings in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

A reversible tracer analysis approach to the study of effective dopamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Nicotine modulates dopamine synthesis rate as determined by L-[beta-11C]DOPA: PET studies compared with [11C]raclopride binding in the conscious monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Novel observations with FDOPA-PET imaging after early nigrostriatal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858409338217

21 January 2018

Identifiers

DOI

10.1177/1073858409338217

1 reference

21 August 2017

1 reference

PubMed ID

19793723